Inventor
YANG BING-SHIOU
US13 patents
⚠️ This page may combine multiple inventors who share the name “YANG BING-SHIOU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER INGELHEIM INT
6 patentsUS9802954B2Oct 31, 2017
Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
BOEHRINGER INGELHEIM INT2 citations71
US11447474B2Sep 20, 2022
Solid forms of a GlyT1 inhibitor
BOEHRINGER INGELHEIM INT2 citations70
US10745411B2Aug 18, 2020
Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
BOEHRINGER INGELHEIM INT1 citations70
US12275722B2Apr 15, 2025
Process of reworking a crystalline form of a glycine transport inhibitor
BOEHRINGER INGELHEIM INT1 citations55
US9120769B2Sep 1, 2015
Aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
BOEHRINGER INGELHEIM INT0 citations48
US9382240B2Jul 5, 2016
Crystalline salts of a potent HCV inhibitor
BOEHRINGER INGELHEIM INT0 citations45
BRISTOL MYERS SQUIBB CO
2 patentsUS7851476B2Dec 14, 2010
Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine
BRISTOL MYERS SQUIBB CO16 citations79
US7371864B2May 13, 2008
Crystalline forms of a factor Xa inhibitor
BRISTOL MYERS SQUIBB CO7 citations71
POUZET PASCALE A J
2 patentsBOEHRINGER INGELHEIM VETMEDICA GMBH
2 patentsUS11629161B2Apr 18, 2023
Synthesis of 1:1:1 co-crystal of 1-cyano-2-(4-cyclopropyl-benzyl)-4-(ß-d-glucopyranos-1-yl)-benzene, L-proline and water
BOEHRINGER INGELHEIM VETMEDICA GMBH1 citations71
US11225500B2Jan 18, 2022
Synthesis of 1:1:1 co-crystal of 1-cyano-2-(4-cyclopropyl-benzyl)-4-(β-D-glucopyranos-1-yl)-benzene, L-proline and water
BOEHRINGER INGELHEIM VETMEDICA GMBH1 citations60